{"id":48,"date":"2019-11-05T13:18:21","date_gmt":"2019-11-05T11:18:21","guid":{"rendered":"https:\/\/www.imunomed.ro\/?p=48"},"modified":"2021-08-03T17:55:41","modified_gmt":"2021-08-03T15:55:41","slug":"burnout-syndrome-immunology-2-2-2","status":"publish","type":"post","link":"https:\/\/www.imunomed.ro\/?p=48&lang=ro","title":{"rendered":"Sindromul Burnout \u2013 imunologie"},"content":{"rendered":"<p>Sindromul Burnout, descris din anii 1970 de Herbert Freudenberger, a prezentat, \u00een ultimii ani, o evolu\u021bie spre agravare, culmin\u00e2nd, \u00een ultimul an, cu evolu\u021bia nea\u0219teptat\u0103 spre excitus, la unii medici, de unde rezult\u0103 implicarea de tip encefalopatic a sistemului nervos central, probabil prin afectarea, \u00een principal, a sistemului reticulat al trunchiului cerebral implicat majoritar \u00een men\u021binerea st\u0103rii de tonus a scoar\u021bei cerebrale.<br \/>\n\u00cen formule severe, afectarea este de tip letargic. Modific\u0103rile de tip comatos la nivelul sistemului nervos central pare c\u0103 are un substrat organic. Nu pot fi explicate numai prin suprasolicitare \u0219i stres.<br \/>\nEste interesant c\u0103, \u00een \u021b\u0103ri asiatice ca Japonia, China, unde sunt regimuri de lucru intensive, nu s-au raportat at\u00e2tea cazuri ca \u00een America \u0219i Europa.<br \/>\nAceea\u0219i afectare de tip astenie psihogen\u0103 este descris\u0103 \u0219i \u00een Sindromul Oboselii Cronice (S.O.C). Acest sindrom, numit \u0219i \u201dnevroza astenic\u0103\u201d, are \u00een comun astenia, sc\u0103derea vigilen\u021bei \u0219i depresia. Diferen\u021ba este c\u0103 S.O.C se \u00eent\u00e2lne\u0219te, mai frecvent, la femei \u0219i se \u00eenso\u021be\u0219te, uneori, de simptome secundare de tip toxico-infec\u021bios (febr\u0103, frisoane, mialgii, astalgii) \u0219i are prognostic bun, f\u0103r\u0103 afectare vital\u0103.<br \/>\nS-ar putea s\u0103 fie dou\u0103 variante ale aceluia\u0219i sindrom cu etiologii diferite sau cu susceptibilitate genetic\u0103 diferit\u0103, av\u00e2nd mecanism patogenic comun. Pare implicat, \u00een principal, sistemul reticulat activator ascendent \u0219i descendent inhibitor, prezent\u00e2nd o multitudine de sinapse.<br \/>\nEste posibil ca astenia psihic\u0103 s\u0103 fie generat\u0103 prin anticorpi care blocheaz\u0103 influxul nervos la diverse nivele, similar blocajului pl\u0103cii neuromotorii din miastenia gravis.<br \/>\nAfectarea nu este de tip clasic (bacterian, viral\u0103, parazitar\u0103, fungic\u0103, metabolic\u0103 sau toxic\u0103 primitiv\u0103 sau secundar\u0103) dar poate fi o afectare de tip imunologic.<br \/>\nLipsa semnelor neurologice evidente extrapiramidale poate fi explicat\u0103 prin afectarea difuz\u0103 \u0219i evolu\u021bia cronic\u0103, precum \u00een miastenia gravis (neuronul, probabil, cap\u0103t\u0103 rezisten\u021b\u0103 , deoarece afectarea nu este direct\u0103, ci indirect\u0103, prin anticorpii blocan\u021bi).<br \/>\n\u00cen miastenia gravis este descris un mecanism de blocaj prin anticorpi la nivelul pl\u0103cii neuro-musculare, f\u0103r\u0103 leziuni inflamatorii sau cu leziuni minime.<br \/>\n\u0218i \u00een miastenia gravis, \u0219i \u00een sindromul miasteniform, examenul neurologic poate s\u0103 nu eviden\u021bieze semne clinice, diagnosticul pun\u00e2ndu-se prin test miastenic, respectiv test miasteniform \u0219i determin\u0103ri imunologice.<br \/>\nTeoria bloc\u0103rii prin aglutinare (mecanismul tip V \u2013 dup\u0103 unii autori, IIb &#8211; ) al reac\u021biilor de hipersensibilitate este \u00eent\u00e2lnit \u0219i \u00een boala \u201dBasedow Graves\u201d (anticorpi stimulan\u021bi ai receptorilor de TSH). \u00cen diabetul zaharat insulino-rezistent este \u00eent\u00e2lnit\u0103 inhibi\u021bia cupl\u0103rii insulinei la receptorul de insulin\u0103.<br \/>\n\u0218i \u00een anemia Biermer apar anticorpi neutralizan\u021bi ai factorului intrinsec iar \u00een anemiile parabiermeriene pot ap\u0103rea anticorpi prin cross-reacts, la bothriocephalus. Anticorpii pot fi rezulta\u021bi prin cross-reactivitate cu antigene microbiene sau chimice.<br \/>\nColina este unul dintre principalii mediatori folosi\u021bi de mul\u021bi parazi\u021bi: este posibil ca, prin cross-reactivity, s\u0103 determine sinteza de anticorpi antiacetilcolin\u0103 periferic, \u00een miastenia gravis, \u00een afectarea SNC \u2013 acetilcolin\u0103 cerebral\u0103?<br \/>\n\u00cen maladia Alzheimer, unde este mult vehiculat\u0103 teoria parazi\u021bilor dormanzi, s-ar putea s\u0103 fie implicat acela\u0219i mecanism cu anticorpi antiacetilcolin\u0103 cerebral\u0103 deoarece \u0219i aceast\u0103 maladie asociaz\u0103 astenie psihic\u0103, uneori, \u00eenso\u021bit\u0103 de depresii.<br \/>\nO alt\u0103 grup\u0103 mare de astenii psihice este grupa celor induse medicamentos. Interferonul are, ca reac\u021bie advers\u0103 principal\u0103, astenia marcat\u0103, reversibil\u0103 la \u00eentreruperea tratamentului. Unii autori au descris interferonii ca av\u00e2nd propriet\u0103\u021bi de neuromediatori SNC, deci este posibil ca astenia s\u0103 fie indus\u0103 prin ac\u021biunea direct\u0103 la nivelul sistemului nervos central sau tot prin mecanism imunologic (\u00een hepatitele cronice sub tratament cu interferon apar multe manifest\u0103ri autoimune \u0219i anticorpi antiinterferon).<br \/>\nAstenia indus\u0103 de Interferon este, uneori, foarte marcat\u0103 dar cedeaz\u0103 destul de repede la oprirea tratamentului \u0219i nu s-au raportat cazuri de exitus, deci pare mai mult indus\u0103 prin mecanism direct.<br \/>\n\u00cen sindromul Burnout, astenia persist\u0103 mai multe luni p\u00e2n\u0103 la c\u00e2\u021biva ani de la scoaterea din mediul profesional deci pare implicat un mecanism imunologic. Agentul cauzal poate fi una din chimicalele mediului de lucru, comun \u00een toate mediile (\u201dsindromul de job\u201d), iar limfocitele cu memorie din cadrul memoriei imunologice pot persista c\u00e2\u021biva ani de la \u00eendep\u0103rtarea antigenului.<br \/>\n\u00cen miastenia gravis, \u00een stadiile finale, exitus-ul apare printr-o reac\u021bie de blocaj imunologic la nivelul mu\u0219chilor respiratori, f\u0103r\u0103 leziuni de tip inflamator, metabolic sau toxic.<br \/>\nDac\u0103 acela\u0219i mecanism de blocaj imunologic func\u021bioneaz\u0103 \u0219i la nivelul sistemului reticulat al trunchiului cerebral \u00een sindromul Burnout, s-ar putea s\u0103 fie eficiente \u00eencerc\u0103rile de plasmoferez\u0103.<\/p>\n<p>Sindromul Burnout, spre deosebire de sindromul oboselii cronice, apare, mai frecvent, la b\u0103rba\u021bi. Are ca simptome astenie, sc\u0103derea tonusului fizic \u0219i psihic, sc\u0103derea randamentului mental \u0219i a eficacit\u0103\u021bii profesionale.<br \/>\nSindromul oboselii cronice a fost redenumit \u201dencefalit\u0103 mialgic\u0103\u201d sau \u201dsindromul cronic al disfunc\u021biei imunitare\u201d \u0219i a fost studiat de echipa de cercet\u0103tori de la National Cancer Institute (SUA, 1985) \u0219i de o echip\u0103 de cercet\u0103tori germani \u00een ideea implic\u0103rii virusurilor herpes tip I sau II sau a virusului HHV \u2013 6, agentul roseola infantum la copil. Mai t\u00e2rziu, studiile au fost completate cu rezonan\u021ba magnetic\u0103.<br \/>\nAl\u021bi agen\u021bi posibil implica\u021bi sunt: virusul Ebstein-Bars (anticorpi anti-Ebstein-Bars prezen\u021bi inconstant), candida albicans (posibil etiologic parazitar\u0103).<br \/>\n\u00cen Rom\u00e2nia, la Bucure\u0219ti, au fost tratate dou\u0103 cazuri care au \u00eendeplinit criteriile diagnostice: Gay Holmes \u2013 Atllanta, 1988 \u2013 (cu excluderea altor cauze de astenie), cazuri ameliorate cu tratamentul cu Albendazol.<br \/>\nUnul dintre cazuri a fost cu anticorpi antitoxocare canis pozitiv, cel\u0103lalt cu anticorpi antitoxocare canis nedetectabili, cu pozitivare sub tratament prob\u0103 cu Albendazol \u0219i Dietilcarbamazin\u0103.<br \/>\n\u00cen afar\u0103 de etiologia infec\u021bioas\u0103, \u00een sindromul oboselii cronice a fost discutat\u0103 \u0219i posibila etiologie chimic\u0103. Boala a fost descris\u0103, mai \u00eent\u00e2i, \u00een \u201dlumea industrial\u0103\u201d, fiind \u00eencadrat\u0103 de unii cercet\u0103tori \u00een \u201dsindromul de sensibilitate chimic\u0103 multipl\u0103\u201d prin ac\u021biunea unor diverse substan\u021be chimice (formaldehida, metale grele \u2013 plumb, magneziu, cadmiu &#8211; , conservan\u021bi, coloran\u021bi, arome alimentare, dioxin\u0103 \u2013 informa\u021bie publicat\u0103 \u00een \u201dAgenda medical\u0103, 1993-1994, Bucure\u0219ti).<br \/>\n\u00cen sindromul oboselii cronice pare mai probabil\u0103 etiologia infec\u021bioas\u0103 iar \u00een sindromul Burnout, etiologia chimic\u0103, la persoanele care prezint\u0103 o susceptibilitate genetic\u0103.<br \/>\nCercet\u0103torii de la universitatea Griffith au identificat biomarkeri de sceening \u0219i evolu\u021bie: polimorfismul singular de nucleotide.<br \/>\nFrecven\u021ba crescut\u0103 a sindromului Burnout \u00een domeniul medical, unde s-au \u00eenregistrat decese la medici, orienteaz\u0103 spre agentul cel mai folosit \u00een toate mediile profesionale din America \u0219i Europa: solu\u021biile de sp\u0103lare a suprafe\u021belor (pardoseli) sau produ\u0219ii rezulta\u021bi prin ac\u021biunea acestora asupra pardoselilor.<br \/>\nRezisten\u021ba la chirurgi care, paradoxal, desf\u0103\u0219oar\u0103 o munc\u0103 intens\u0103 \u0219i, de asemenea, la infirmiere, este \u00een sprijinul teoriei imunologice: pare c\u0103 ace\u0219tia au rezisten\u021b\u0103 prin contact intens \u0219i prelungit cu m\u00e2inile.<br \/>\nLa scoaterea din mediu, simptomatologia persist\u0103 mai mult timp (variabil, p\u00e2n\u0103 la c\u00e2teva luni sau c\u00e2\u021biva ani) prin persisten\u021ba memoriei imunologice, spijinind astfel ideea c\u0103 mecanismul nu este toxic direct ci, probabil, este imunologic.<br \/>\nDintre reac\u021biile de hipersensibilitate, cel mai probabil pare a fi tipul V (II b) care are ca prototip miastenia gravis. Celelalte tipuri de hipersensibilitate se exclud clinic \u0219i paraclinic:<br \/>\n&#8211; tipul I alergic, mediat de IgE specifice;<br \/>\n&#8211; tipul IIa, mediat de anticorpi \u0219i complement;<br \/>\n&#8211; tipul III, mediat de complexele imune circulante \u2013 prototip boala serului;<br \/>\n&#8211; tipul IV granulomatos (reac\u021bii granulomatoase la dioxid de siliciu, talc), frecvent \u00eent\u00e2nit la bolile profesionale, testat prin testul de transformare limfoblastic\u0103.<br \/>\nR\u0103m\u00e2ne \u00een discu\u021bie tipul V (II b) cu anticorpi care modific\u0103 semnalizarea la nivelul unor receptori celulari de suprafa\u021b\u0103, similar miasteniei gravis. Anticorpii pot ap\u0103rea prin cross-reacts cu antigene infec\u021bioase sau chimice. Este posibil ca unele cazuri acutizate severe s\u0103 necesite plasmaferez\u0103.<br \/>\nDintre clasele de Ig, cele mai frecvent implicate \u00een acest tip de reac\u021bii sunt IgG \u0219i IgN. Subclasa IgG4 nu are legare pe receptorii Fc pentru macrofag sau complement deci nu prea are capacit\u0103\u021bi de opromizer. Perioada lui de \u00eenjum\u0103t\u0103\u021bire, \u201dhalf-life\u201d, este de 23 de zile \u0219i el particip\u0103 mult la transferul placentar \u0219i anafilaxia cutanat\u0103 pasiv\u0103.<br \/>\nDe asemenea, este inclus \u0219i \u00een cursul tratamentelor de desensibilizare alergologic\u0103 cu rol protectiv fa\u021b\u0103 de anticorpii IgE. Uneori, se constat\u0103 forma monocatenar\u0103 (cu un singur lan\u021b L \u0219i un singur lan\u021b H), care particip\u0103 la reac\u021biile de blocaj.<br \/>\n\u00cen ceea ce prive\u0219te distribu\u021bia geografic\u0103 a sindromului, studiile au eviden\u021biat o frecven\u021b\u0103 ridicat\u0103 a epuiz\u0103rii \u00een Spania \u0219i Portugalia, o frecven\u021b\u0103 ridicat\u0103 a depresiei \u0219i sc\u0103zut\u0103 a asteniei \u00een Germania \u0219i o frecven\u021b\u0103 sc\u0103zut\u0103 a epuiz\u0103rii \u00een Anglia.<br \/>\nConform unor studii americane, locuri ridicate ocup\u0103 neurologia iar dup\u0103 altele, oncologia. Aici, pacien\u021bii au un mers special \u00eencetinit, denatur\u00e2nd, poate, solu\u021biile de pardoseli prin frecare prelungit\u0103.<br \/>\nPacien\u021bii care au decedat \u00een aceste sec\u021bii sunt dintre medicii care au folosit mai mult de dou\u0103 zile camera de gard\u0103; poate c\u0103 au \u00eenregistrat un surplus \u00een \u00eenc\u0103rcarea antigenic\u0103, inclusiv noaptea, \u00een somn (posibil inhalator?).<br \/>\nAceasta ar explica de ce sec\u021biile clinice au inciden\u021b\u0103 mai mare versus sec\u021biile de cercetare \u0219i colectivit\u0103\u021bile de studen\u021bi la medicin\u0103. Este posibil s\u0103 conteze \u0219i criteriul v\u00e2rstei sau criteriul genetic (Japonia).<br \/>\nSe pare c\u0103, prin denaturarea solu\u021biilor de pardoseli, se genereaz\u0103 produ\u0219i ioda\u021bi sau similari deoarece astenia se accentueaz\u0103 la consumul alimentelor ce par bogate \u00een iod (p\u00e2ine neagr\u0103, nuci). Rezisten\u021ba mare \u00een chirurgie ar fi un argument \u00een plus \u00eentruc\u00e2t chirurgii folosesc mult compu\u0219ii ioda\u021bi. Se pare c\u0103 \u0219i rasa asiatic\u0103 manifest\u0103 o rezisten\u021b\u0103 genetic\u0103 la ace\u0219ti produ\u0219i. De asemenea, englezii par a avea o rezisten\u021b\u0103 mai mare, \u00een timp ce americanii au o rezisten\u021b\u0103 scazut\u0103.<\/p>\n<p style=\"text-align: right;\">Mihaela Ghimpu<br \/>\nMedic specialist imunologie clinic\u0103<br \/>\n\u0219i alergologie<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sindromul Burnout, descris din anii 1970 de Herbert Freudenberger, a prezentat, \u00een ultimii ani, o evolu\u021bie spre agravare, culmin\u00e2nd, \u00een ultimul an, cu evolu\u021bia nea\u0219teptat\u0103 spre excitus, la unii medici, de unde rezult\u0103 implicarea de tip encefalopatic a sistemului nervos central, probabil prin afectarea, \u00een principal, a sistemului reticulat al [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16,7],"tags":[],"class_list":["post-48","post","type-post","status-publish","format-standard","hentry","category-sindroame-ro","category-uncategorized-ro"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Sindromul Burnout \u2013 imunologie - Imunomed<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.imunomed.ro\/?p=48&lang=ro\" \/>\n<meta property=\"og:locale\" content=\"ro_RO\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sindromul Burnout \u2013 imunologie - Imunomed\" \/>\n<meta property=\"og:description\" content=\"Sindromul Burnout, descris din anii 1970 de Herbert Freudenberger, a prezentat, \u00een ultimii ani, o evolu\u021bie spre agravare, culmin\u00e2nd, \u00een ultimul an, cu evolu\u021bia nea\u0219teptat\u0103 spre excitus, la unii medici, de unde rezult\u0103 implicarea de tip encefalopatic a sistemului nervos central, probabil prin afectarea, \u00een principal, a sistemului reticulat al [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.imunomed.ro\/?p=48&amp;lang=ro\" \/>\n<meta property=\"og:site_name\" content=\"Imunomed\" \/>\n<meta property=\"article:published_time\" content=\"2019-11-05T11:18:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-08-03T15:55:41+00:00\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Scris de\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Timp estimat pentru citire\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.imunomed.ro\\\/?p=48&lang=ro#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.imunomed.ro\\\/?p=48&lang=ro\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/www.imunomed.ro\\\/#\\\/schema\\\/person\\\/1c85e72766d24a7ec82815bb2686b618\"},\"headline\":\"Sindromul Burnout \u2013 imunologie\",\"datePublished\":\"2019-11-05T11:18:21+00:00\",\"dateModified\":\"2021-08-03T15:55:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.imunomed.ro\\\/?p=48&lang=ro\"},\"wordCount\":1643,\"publisher\":{\"@id\":\"https:\\\/\\\/www.imunomed.ro\\\/#\\\/schema\\\/person\\\/1c85e72766d24a7ec82815bb2686b618\"},\"articleSection\":[\"sindroame\",\"Uncategorized\"],\"inLanguage\":\"ro-RO\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.imunomed.ro\\\/?p=48&lang=ro\",\"url\":\"https:\\\/\\\/www.imunomed.ro\\\/?p=48&lang=ro\",\"name\":\"Sindromul Burnout \u2013 imunologie - Imunomed\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.imunomed.ro\\\/#website\"},\"datePublished\":\"2019-11-05T11:18:21+00:00\",\"dateModified\":\"2021-08-03T15:55:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.imunomed.ro\\\/?p=48&lang=ro#breadcrumb\"},\"inLanguage\":\"ro-RO\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.imunomed.ro\\\/?p=48&lang=ro\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.imunomed.ro\\\/?p=48&lang=ro#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Prima pagin\u0103\",\"item\":\"https:\\\/\\\/www.imunomed.ro\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sindromul Burnout \u2013 imunologie\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.imunomed.ro\\\/#website\",\"url\":\"https:\\\/\\\/www.imunomed.ro\\\/\",\"name\":\"Imunomed\",\"description\":\"Imunitate si alergologie\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.imunomed.ro\\\/#\\\/schema\\\/person\\\/1c85e72766d24a7ec82815bb2686b618\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.imunomed.ro\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ro-RO\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/www.imunomed.ro\\\/#\\\/schema\\\/person\\\/1c85e72766d24a7ec82815bb2686b618\",\"name\":\"admin\",\"logo\":{\"@id\":\"https:\\\/\\\/www.imunomed.ro\\\/#\\\/schema\\\/person\\\/image\\\/\"},\"url\":\"https:\\\/\\\/www.imunomed.ro\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sindromul Burnout \u2013 imunologie - Imunomed","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.imunomed.ro\/?p=48&lang=ro","og_locale":"ro_RO","og_type":"article","og_title":"Sindromul Burnout \u2013 imunologie - Imunomed","og_description":"Sindromul Burnout, descris din anii 1970 de Herbert Freudenberger, a prezentat, \u00een ultimii ani, o evolu\u021bie spre agravare, culmin\u00e2nd, \u00een ultimul an, cu evolu\u021bia nea\u0219teptat\u0103 spre excitus, la unii medici, de unde rezult\u0103 implicarea de tip encefalopatic a sistemului nervos central, probabil prin afectarea, \u00een principal, a sistemului reticulat al [&hellip;]","og_url":"https:\/\/www.imunomed.ro\/?p=48&lang=ro","og_site_name":"Imunomed","article_published_time":"2019-11-05T11:18:21+00:00","article_modified_time":"2021-08-03T15:55:41+00:00","author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Scris de":"admin","Timp estimat pentru citire":"8 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.imunomed.ro\/?p=48&lang=ro#article","isPartOf":{"@id":"https:\/\/www.imunomed.ro\/?p=48&lang=ro"},"author":{"name":"admin","@id":"https:\/\/www.imunomed.ro\/#\/schema\/person\/1c85e72766d24a7ec82815bb2686b618"},"headline":"Sindromul Burnout \u2013 imunologie","datePublished":"2019-11-05T11:18:21+00:00","dateModified":"2021-08-03T15:55:41+00:00","mainEntityOfPage":{"@id":"https:\/\/www.imunomed.ro\/?p=48&lang=ro"},"wordCount":1643,"publisher":{"@id":"https:\/\/www.imunomed.ro\/#\/schema\/person\/1c85e72766d24a7ec82815bb2686b618"},"articleSection":["sindroame","Uncategorized"],"inLanguage":"ro-RO"},{"@type":"WebPage","@id":"https:\/\/www.imunomed.ro\/?p=48&lang=ro","url":"https:\/\/www.imunomed.ro\/?p=48&lang=ro","name":"Sindromul Burnout \u2013 imunologie - Imunomed","isPartOf":{"@id":"https:\/\/www.imunomed.ro\/#website"},"datePublished":"2019-11-05T11:18:21+00:00","dateModified":"2021-08-03T15:55:41+00:00","breadcrumb":{"@id":"https:\/\/www.imunomed.ro\/?p=48&lang=ro#breadcrumb"},"inLanguage":"ro-RO","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.imunomed.ro\/?p=48&lang=ro"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.imunomed.ro\/?p=48&lang=ro#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Prima pagin\u0103","item":"https:\/\/www.imunomed.ro\/"},{"@type":"ListItem","position":2,"name":"Sindromul Burnout \u2013 imunologie"}]},{"@type":"WebSite","@id":"https:\/\/www.imunomed.ro\/#website","url":"https:\/\/www.imunomed.ro\/","name":"Imunomed","description":"Imunitate si alergologie","publisher":{"@id":"https:\/\/www.imunomed.ro\/#\/schema\/person\/1c85e72766d24a7ec82815bb2686b618"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.imunomed.ro\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ro-RO"},{"@type":["Person","Organization"],"@id":"https:\/\/www.imunomed.ro\/#\/schema\/person\/1c85e72766d24a7ec82815bb2686b618","name":"admin","logo":{"@id":"https:\/\/www.imunomed.ro\/#\/schema\/person\/image\/"},"url":"https:\/\/www.imunomed.ro\/?author=1"}]}},"lang":"ro","translations":{"en":78,"ro":48},"pll_sync_post":[],"_links":{"self":[{"href":"https:\/\/www.imunomed.ro\/index.php?rest_route=\/wp\/v2\/posts\/48","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.imunomed.ro\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.imunomed.ro\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.imunomed.ro\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.imunomed.ro\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=48"}],"version-history":[{"count":3,"href":"https:\/\/www.imunomed.ro\/index.php?rest_route=\/wp\/v2\/posts\/48\/revisions"}],"predecessor-version":[{"id":92,"href":"https:\/\/www.imunomed.ro\/index.php?rest_route=\/wp\/v2\/posts\/48\/revisions\/92"}],"wp:attachment":[{"href":"https:\/\/www.imunomed.ro\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=48"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.imunomed.ro\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=48"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.imunomed.ro\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=48"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}